Search

Displaying 11 - 20 of 428

(April 14, 2022, AUSTIN, TX) —The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the results of the trial are not final, they offer valuable information for patients using the generic drug Spironolactone. This drug therapy activates white cells and...

(April 12, 2023, New York, NY) — The National Kidney Foundation (NKF) will feature a late-breaking plenary session by Travere Therapeutics on the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) in adults with IgA nephropathy (IgAN). “Rapid and Sustained Proteinuria Reduction with Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results...

Choosing soy protein (such as tofu and soy beans) and other vegetable protein sources instead of meats may mean a lower risk of kidney disease for people with Type 2 diabetes. Vegetarian diets may decrease the amount of protein lost in urine, the renal acid load, and renal hyperfiltration...

When it comes to dairy products in our everyday food intake, most people would say that they have milk or other dairy products daily, if not more! Milk, cheese, cottage cheese, yogurts, pudding and ice cream are some of the favorite dairy products of young and old alike. Dairy products are naturally abundant in protein, B vitamins, calcium, phosphorus and potassium. All of these nutrients are important for our body’s many functions....

March 31, 2022, New York, NY — Researchers will present at the National Kidney Foundation’s Spring Clinical Meetings the results of a clinical trial of a new therapy that gives hope to people with a specific genetic mutation that can cause kidney damage. 

APOL1-mediated kidney disease (AMKD) is a serious disease caused by mutations in the APOL1 gene that lead to damage in certain...